Patent 4035511 Issued on July 12, 1977. Estimated Expiration Date: July 12, 1994. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Analgesia is produced or hyperalgesia is reduced in an animal including human beings by administering 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine either along or with morphine sulfate. A novel composition is provided comprising 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and 25 to 50 weight percent morphine sulfate based upon the weight of the phenylpropylamine.
Other References
terry et al., Fed. Proc., vol. 33, p. 560 (1974)
Fuller et al., Journal of Pharmacology & Experimental Therapeutics, vol. 19, pp. 796-803 (1975)